The board of Sarama Resources Ltd (trading as TSXV:SWA and ASX:SRR) announced on 20 May 2026 that it has secured binding commitments for a private placement targeted to raise A$1.5 million before costs. The placement attracted support from existing institutional, professional and sophisticated investors, and will be used to progress the company’s early-stage copper-gold work in New South Wales while preserving working capital as the firm advances an international arbitration claim. This action follows recent portfolio adjustments designed to concentrate Sarama’s exposure on high-potential exploration ground and legal recourse related to its prior West African assets.
Placement structure and mechanics
The offer comprises up to 42,857,142 CDIs priced at A$0.035 per CDI, representing a modest discount to recent trading levels. Under the terms, the issue will be split into two tranches: Tranche 1 of 40,521,428 CDIs to be issued under ASX placement capacity and Tranche 2 of up to 2,335,714 CDIs subject to shareholder approval at the Annual General Meeting anticipated in late August 2026. The company expects settlement of the placement on Monday 25 May 2026 with allotment of CDIs on Wednesday 27 May 2026, and finalisation remains conditional on approval by the TSXV.
Use of proceeds and project focus
Funds will be channelled primarily into advancing the company’s three early-stage copper-gold projects in New South Wales within the prospective Lachlan Fold Belt, with the balance retained for general working capital purposes. Management emphasises that the injection of cash is timed to support exploration activity while maintaining capacity to pursue the company’s legal claim overseas. The placement allotments will rank equally with existing securities and each new CDI will represent beneficial interest in one common share, ensuring parity for new investors with the current register.
Board participation, fees and regulatory notes
Members of Sarama’s board and executive team intend to subscribe to the placement, which classifies their involvement as a related party transaction under Canadian MI 61-101. Because their aggregate participation falls below the materiality threshold specified in that instrument, Sarama has relied on exemptions from formal valuation and minority shareholder approval while committing to file the requisite material change reports. A 6% finder’s fee is payable on equity directly procured by any appointed finder.
Arbitration update and legal funding
In parallel with the capital raise, Sarama continues to pursue arbitration against the Government of Burkina Faso through the International Centre for Settlement of Investment Disputes (ICSID), seeking no less than US$242 million plus interest in relation to the alleged unlawful expropriation of its Sanutura gold project. The claim is financed by a non-recourse litigation funding facility of US$4.4 million, and legal counsel is provided by Boies Schiller Flexner (UK) LLP. The arbitration docket has progressed through several procedural stages, including confirmation of the procedural timetable, exchange of memorials, and scheduling of the merits hearing for February 2027.
Strategic asset sale and outlook
To sharpen its capital structure and reduce shareholder dilution, Sarama agreed on 21 April 2026 to sell its Western Australian gold assets to Riedel Resources Ltd for approximately A$4.6 million in a mix of cash and equity. Upon completion, Sarama is expected to hold an initial near-32% post-money interest in Riedel, potentially rising to about 44% if performance rights vest and are exercised. Management frames this transaction as a way to retain upside exposure to the WA portfolio while focusing corporate resources on the NSW copper-gold opportunities and on advancing the ICSID claim.
Executive Chairman Andrew Dinning noted that the placement’s reception by existing shareholders and institutional participants reflects confidence in the company’s dual strategy of targeted exploration and disciplined legal action. The board will continue to monitor timelines for regulatory approvals, the outcome of the shareholder vote for Tranche 2 at the Annual General Meeting, and progress in the arbitration process. Investors should be mindful that forward-looking elements related to exploration success, legal outcomes and financing are subject to significant uncertainties as disclosed in Sarama’s public filings.
